JJBC
MRNA icon

James J. Burns & Company’s Moderna MRNA Stock Holding History

James J. Burns & Company’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-2,425
Closed -$288K – 143
2024
Q2 		$288K Buy
+2,425
New +$307K 0.06% 104
2024
Q1 		– Sell
-2,425
Closed -$241K – 105
2023
Q4 		$241K Buy
+2,425
New +$204K 0.06% 108

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

James J. Burns & Company's MRNA Position: Q3 2024 in Review

James J. Burns & Company sold out of Moderna (MRNA) in Q3 2024, closing a stake of 2,425 shares — an estimated $288K sold.

James J. Burns & Company first reported a position in MRNA in Q4 2023 and held it in 2 quarters. The position peaked at $288K in Q2 2024. 788 funds tracked by Wall St. Rank hold MRNA as of Q3 2024.

  • James J. Burns & Company reported no remaining Moderna position as of Q3 2024 after selling out during the quarter.
  • James J. Burns & Company sold 2,425 Moderna shares in Q3 2024, an estimated $288K.
  • James J. Burns & Company first reported a position in Moderna in Q4 2023 and held it in 2 quarters.
  • James J. Burns & Company's Moderna position peaked at $288K in Q2 2024.
  • 788 funds tracked by Wall St. Rank held Moderna as of Q3 2024.

Based on James J. Burns & Company's 13F filing for Q3 2024, filed 30 Oct 2024.